“ We have set a goal that by 2027, more than 740,000 Korean patients will be benefiting from our treatments ”
“ Building stronger bridges between Korean biotech companies and global capital will be critical to unlocking the ecosystem’s full potential ”
“ Our broader goal is to extend the potential of T-cell engagers across solid tumours and bring T-cell-based immunotherapy to more patients ”
“ We want to pursue areas where circular RNA can do something other modalities cannot ”
“ Korea's real strength right now is active, innovative discovery research, and that expertise, along with international networking, keeps improving ”
“ I believe we can position Korea as a true global leader in biohealth innovation ”
“ We are actively evolving into a nation that discovers innovative drug candidates ”
“ Even a truly great medicine delivers limited value if patients cannot actually benefit from it ”
“ What I want, more than anything, is to introduce this modality to patients as quickly and as properly as possible ”
“ We are no longer a purely Korean company; our ambition is to become a genuinely global player in epilepsy ”
“ Our ambition is to build a company that genuinely operates without borders, contributing to human health across multiple fronts ”
“ With the bioPROTAC platform, we can, in principle, degrade essentially any problematic protein ”
See our Cookie Privacy Policy Here
